Biotech U.S. stocks
Explore U.S. biotechnology stocks on MEXC, covering companies focused on drug discovery, gene therapy, and biological research. Compare stock prices, daily changes, market cap, and trading volume across the biotech sector.

Market Overview
U.S. stocks are broadly lower today, with the Dow Jones down 2.20%, the S&P 500 down 1.99%, and the Nasdaq Composite down 2.23%. Market breadth is negative, with 4,376 stocks declining versus 740 advancing, pointing to a broadly bearish bias.
Biotech Stocks
| # | Stock | 52 Week Range | |||||
|---|---|---|---|---|---|---|---|
| 51 | Attovia Therapeutics, Inc.ATTO | $15.53 | +3.93% | 131.17K | $673.12M | $12.94 - $28.00 | 0.00% |
| 52 | 4D Molecular Therapeutics, Inc.FDMT | $10.71 | +1.91% | 366.00K | $603.54M | $6.96 - $16.93 | 0.00% |
| 53 | DBV Technologies S.A.DBVT | $9.48 | -2.07% | 233.65K | $596.08M | $8.63 - $26.18 | 0.00% |
| 54 | Cullinan Therapeutics, Inc.CGEM | $9.05 | +1.72% | 831.45K | $587.53M | $8.23 - $23.19 | 0.00% |
| 55 | Surrozen, Inc.SRZN | $30.29 | -3.15% | 76.55K | $577.38M | $12.79 - $37.83 | 0.00% |
| 56 | Entera Bio Ltd.ENTX | $3.25 | -1.23% | 212.55K | $565.08M | $0.91 - $4.20 | 0.00% |
| 57 | NRC HealthNRC | $24.99 | -4.80% | 80.69K | $530.33M | $11.73 - $27.60 | 0.02% |
| 58 | Electra Therapeutics, Inc.ETRA | $8.98 | +6.52% | 388.42K | $521.59M | $6.87 - $15.50 | 0.00% |
| 59 | Sana Biotechnology, Inc.SANA | $1.74 | -5.68% | 3.55M | $519.87M | $1.71 - $5.49 | 0.00% |
| 60 | REGENXBIO Inc.RGNX | $7.17 | -0.14% | 521.15K | $474.10M | $5.46 - $16.19 | 0.00% |
| 61 | Fennec Pharmaceuticals Inc.FENC | $13.44 | +1.20% | 416.06K | $473.28M | $5.65 - $13.85 | 0.00% |
| 62 | Ginkgo Bioworks Holdings, Inc.DNA | $8.21 | -1.54% | 2.34M | $442.61M | $5.37 - $18.22 | 0.00% |
| 63 | IRulya Therapeutics Inc.IRLA | $39.85 | -1.63% | 104.58K | $432.04M | $25.13 - $45.00 | 0.00% |
| 64 | Tectonic Therapeutic, Inc.TECX | $21.19 | -0.07% | 65.19K | $422.72M | $16.77 - $39.53 | 0.00% |
| 65 | Candel Therapeutics, Inc.CADL | $5.12 | -2.63% | 983.78K | $391.39M | $4.35 - $14.00 | 0.00% |
| 66 | Alector, Inc.ALEC | $2.31 | -9.73% | 1.41M | $343.16M | $1.09 - $2.84 | 0.00% |
| 67 | C4 Therapeutics, Inc.CCCC | $2.42 | -2.22% | 2.47M | $318.44M | $1.69 - $5.17 | 0.00% |
| 68 | TRex Bio, Inc.TRXB | $9.67 | +3.09% | 177.15K | $295.59M | $9.06 - $16.56 | 0.00% |
| 69 | X4 Pharmaceuticals, Inc.XFOR | $2.96 | +0.51% | 1.03M | $292.98M | $2.43 - $4.83 | 0.00% |
| 70 | Eikon Therapeutics, Inc.EIKN | $4.73 | -7.93% | 329.21K | $291.79M | $4.73 - $17.40 | 0.00% |
| 71 | Scribe Therapeutics Inc.SCTX | $13.20 | -5.48% | 476.38K | $291.07M | $12.58 - $39.60 | 0.00% |
| 72 | Kyverna Therapeutics, Inc.KYTX | $4.37 | -1.00% | 703.91K | $276.34M | $4.30 - $13.67 | 0.00% |
| 73 | Agenus Inc.AGEN | $6.11 | -4.77% | 759.14K | $276.32M | $2.71 - $10.31 | 0.00% |
| 74 | Editas Medicine, Inc.EDIT | $1.71 | -1.13% | 1.73M | $263.15M | $1.66 - $3.94 | 0.00% |
| 75 | SAB Biotherapeutics, Inc.SABS | $2.90 | -11.88% | 1.68M | $261.71M | $2.44 - $5.15 | 0.00% |
| 76 | Ocugen, Inc.OCGN | $0.73 | -1.57% | 8.79M | $249.39M | $0.69 - $2.73 | 0.00% |
| 77 | Lexeo Therapeutics, Inc.LXEO | $2.96 | +3.39% | 1.13M | $242.69M | $2.55 - $10.99 | 0.00% |
| 78 | Century Therapeutics, Inc.IPSC | $1.31 | -6.16% | 694.79K | $238.07M | $0.46 - $3.04 | 0.00% |
| 79 | Allogene Therapeutics, Inc.ALLO | $0.66 | -4.41% | 6.37M | $230.05M | $0.65 - $4.46 | 0.00% |
| 80 | ProKidney Corp.PROK | $1.06 | +2.40% | 1.42M | $222.14M | $0.87 - $2.65 | 0.00% |
| 81 | Cabaletta Bio, Inc.CABA | $1.00 | -2.84% | 2.84M | $215.50M | $0.98 - $4.23 | 0.00% |
| 82 | Alpha Cognition Inc.ACOG | $8.88 | +1.63% | 101.69K | $193.28M | $4.50 - $10.14 | 0.00% |
| 83 | Precision BioSciences, Inc.DTIL | $6.91 | -2.46% | 228.56K | $193.04M | $3.53 - $11.29 | 0.00% |
| 84 | Artiva Biotherapeutics, Inc.ARTV | $3.83 | +2.25% | 693.80K | $189.57M | $2.96 - $14.53 | 0.00% |
| 85 | Inhibikase Therapeutics, Inc.IKT | $1.30 | -4.71% | 409.82K | $183.05M | $1.28 - $2.61 | 0.00% |
| 86 | Palisade Bio, Inc.PALI | $0.92 | -0.56% | 2.57M | $165.65M | $0.92 - $2.85 | 0.00% |
| 87 | Humacyte, Inc.HUMA | $0.54 | +7.16% | 3.65M | $149.73M | $0.34 - $1.52 | 0.00% |
| 88 | Protara Therapeutics, Inc.TARA | $2.40 | +2.56% | 1.15M | $147.46M | $2.09 - $7.82 | 0.00% |
| 89 | Sutro Biopharma, Inc.STRO | $8.70 | +3.18% | 205.34K | $144.37M | $7.15 - $43.85 | 0.00% |
| 90 | MaxCyte, Inc.MXCT | $1.29 | +3.60% | 1.52M | $133.71M | $0.64 - $1.80 | 0.00% |
| 91 | Invivyd, Inc.IVVD | $0.45 | -2.81% | 3.63M | $131.76M | $0.45 - $3.01 | 0.00% |
| 92 | Fate Therapeutics, Inc.FATE | $1.02 | -1.43% | 1.50M | $124.49M | $0.95 - $3.23 | 0.00% |
| 93 | Compass Therapeutics, Inc.CMPX | $0.68 | +9.36% | 1.43M | $121.74M | $0.57 - $6.88 | 0.00% |
| 94 | enGene Therapeutics Inc.ENGN | $1.77 | -3.78% | 983.77K | $118.95M | $1.40 - $12.25 | 0.00% |
| 95 | LENZ Therapeutics, Inc.LENZ | $3.33 | +4.05% | 575.17K | $104.47M | $2.80 - $32.13 | 0.00% |
| 96 | Voyager Therapeutics, Inc.VYGR | $1.60 | -2.10% | 619.65K | $99.88M | $1.48 - $5.48 | 0.00% |
| 97 | Outlook Therapeutics, Inc.OTLK | $0.41 | -0.76% | 6.67M | $98.84M | $0.16 - $2.54 | 0.00% |
| 98 | Tevogen Inc.TVGN | $6.17 | -3.01% | 4.72K | $97.13M | $3.64 - $24.91 | 0.00% |
| 99 | Zura Bio LimitedZURA | $0.95 | -2.18% | 1.72M | $91.61M | $0.92 - $7.44 | 0.00% |
| 100 | Black Diamond Therapeutics, Inc.BDTX | $1.38 | -5.24% | 397.08K | $79.25M | $1.35 - $4.05 | 0.00% |
Trade U.S. stocks Your Way on MEXC
| RealStocks | Tokenized Stocks | Stock Futures | |
|---|---|---|---|
| What it is | RealStocks — real shares of U.S.-listed companies | Blockchain-based tokens linked to U.S. stocks/ETFs | USDT-margined futures on U.S. stock price movements |
| Ownership | Yes — actual shares | No — synthetic exposure only | No — derivative exposure only |
| Shareholder rights | Yes (e.g. dividends) | No | No |
| Trading hours | U.S. market sessions (pre-market, regular, after-hours, overnight) | 24/7 | Up to 24/7 (supported pairs) |
| Position types | Buy and hold | Buy and hold | Long, short, leveraged |
| Best for | Long-term investors seeking ownership and dividend income | Traders wanting round-the-clock access to stock exposure without holding shares | Active/short-term traders looking to speculate or hedge with leverage |
Why Trade U.S. stocks on MEXC?
RealStocks, Real Ownership
Buy real US-listed shares through MEXC's partner licensed broker and receive applicable shareholder benefits, including dividends.
7,000+ U.S. stocks & ETFs
Access 7,000+ US-listed stocks and ETFs across technology, finance, healthcare, consumer sectors, and more.
Seamless USDT-to-Stock Access
Transfer USDT and convert between USDT and USD to fund your RealStocks account with ease.
Lower-Cost Stock Trading
Trade real U.S. stocks with competitive costs and keep more capital available for your investment strategy.
Frequently Asked Questions (FAQ)
What are biotech stocks?
What companies are included in the biotech sector?
Why track biotech stocks?
Which biotech stock has the largest market cap?
What should I look at when comparing biotech stocks?
Why can biotech stocks be volatile?
Discover Top US Stocks
Disclaimer
US stock prices, indices, rankings, charts, and other market data displayed on this page may be sourced from third-party providers and may be delayed or inaccurate. MEXC provides this information for informational and educational purposes only and does not guarantee its accuracy or completeness. Nothing on this page constitutes financial or investment advice or a recommendation to buy or sell any security. US stock trading involves risk, and past performance does not guarantee future results. Users should conduct independent research before making investment decisions.






.b39e813829fa.png)

.b39e815d234d.png)
.b39e81c62f33.png)
.b39e81f7d220.png)
